CLINICAL TRIALS PROFILE FOR CALFACTANT
✉ Email this page to a colleague
All Clinical Trials for Calfactant
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00506532 ↗ | The Use of Surfactant in Lung Transplantation: A Randomized Control Pilot Study | Unknown status | Rabin Medical Center | Phase 2/Phase 3 | 2005-01-01 | 1. Working Hypothesis: The purpose of the trial is to study the effect of exogenous calf surfactant (calfactant) on the prevention of primary graft failure due to ischemic-reperfusion lung injury in lung transplant patients. 2. Aims of the Study: The purpose of the trial is to study the effect of exogenous calf surfactant (calfactant) on the prevention of primary graft failure due to ischemic-reperfusion lung injury in lung transplant patients. |
| NCT00569530 ↗ | Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide | Completed | Mallinckrodt | Phase 3 | 2008-01-01 | The purpose of this study is to determine if the combination of late doses of Infasurf with inhaled nitric oxide will interact to improve the surfactant function and thus the respiratory status and outcome of treated infants. |
| NCT00569530 ↗ | Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide | Completed | ONY | Phase 3 | 2008-01-01 | The purpose of this study is to determine if the combination of late doses of Infasurf with inhaled nitric oxide will interact to improve the surfactant function and thus the respiratory status and outcome of treated infants. |
| NCT00569530 ↗ | Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide | Completed | Roberta Ballard | Phase 3 | 2008-01-01 | The purpose of this study is to determine if the combination of late doses of Infasurf with inhaled nitric oxide will interact to improve the surfactant function and thus the respiratory status and outcome of treated infants. |
| NCT00569530 ↗ | Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide | Completed | University of California, San Francisco | Phase 3 | 2008-01-01 | The purpose of this study is to determine if the combination of late doses of Infasurf with inhaled nitric oxide will interact to improve the surfactant function and thus the respiratory status and outcome of treated infants. |
| NCT00628134 ↗ | Self-dispersing Liquids as Aerosol Drug Carriers | Completed | Cystic Fibrosis Foundation | N/A | 2008-03-01 | Inhaled medications are often used to treat lung diseases such as cystic fibrosis. We are performing this study to determine whether inhaled medications dissolved in surfactant-based solutions will distribute more evenly throughout the lungs when compared to standard saline-based solutions. We think that inhaling medication that is in a surfactant-based liquid will result in more medication reaching partially blocked parts of the lung. This study will use a special nuclear medicine test called an aerosol deposition scan to compare how a drug spreads in the lung using a surfactant-based aerosol compared to a saline-based aerosol. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Calfactant
Condition Name
| Condition Name for Calfactant | |
| Intervention | Trials |
| Bronchopulmonary Dysplasia | 4 |
| Respiratory Distress Syndrome | 3 |
| Respiratory Distress Syndrome of Prematurity (Surfactant Dysfunction) | 1 |
| Respiratory Distress Syndrome, Adult | 1 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Condition MeSH
Clinical Trial Locations for Calfactant
Trials by Country
Clinical Trial Progress for Calfactant
Clinical Trial Phase
Clinical Trial Sponsors for Calfactant
Sponsor Name
